Mediclinic International plc Directorate Change (6654D)
21 February 2020 - 9:00PM
UK Regulatory
TIDMMDC
RNS Number : 6654D
Mediclinic International plc
21 February 2020
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company", or the "Group")
21 February 2020
DIRECTORATE CHANGE
Following the previous announcement made on 16 January 2020, the
Company confirms that Mr Seamus Keating, who serves as an
independent non-executive director, will step down from the Board
of Mediclinic on 31 March 2020. Mr Keating's intention to retire
from the Board was announced subsequent to his appointment as Chief
Executive Officer of First Derivatives plc with effect from 15
January 2020. Mr Keating will also resign from all Board
subcommittees at that time which include the Audit and Risk
Committee, Remuneration Committee and Clinical Performance and
Sustainability Committee.
The Board will shortly commence a process to identify a suitable
replacement for Mr Keating, with an announcement to follow
accordingly.
This announcement is made in accordance with the requirement of
LR 9.6.11.
About Mediclinic International plc
Mediclinic is an international private healthcare services
group, established in South Africa in 1983, with divisions in
Switzerland, Southern Africa (South Africa and Namibia) and the
United Arab Emirates.
The Group's core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for
all their healthcare needs.
Mediclinic is focused on providing specialist-orientated,
multi-disciplinary services across the continuum of care in such a
way that the Group will be regarded as the most respected and
trusted provider of healthcare services by patients, medical
practitioners, funders and regulators of healthcare in each of its
markets.
As at 1 February 2020, Mediclinic comprised 77 hospitals, five
sub-acute hospitals, 14 day case clinics and 22 outpatient clinics.
Hirslanden operated 17 hospitals, two day case clinics and three
outpatient clinics in Switzerland with more than 1 900 inpatient
beds; Mediclinic Southern Africa operations included 53 hospitals
(three of which in Namibia), five sub-acute hospitals and 10 day
case clinics (four of which operated by Intercare) across South
Africa, and more than 8 500 inpatient beds; and Mediclinic Middle
East operated seven hospitals, two day case clinics and 19
outpatient clinics with more than 900 inpatient beds in the United
Arab Emirates.
The Company's primary listing is on the London Stock Exchange
("LSE") in the United Kingdom, with secondary listings on the JSE
Ltd ("JSE") in South Africa and the Namibian Stock Exchange ("NSX")
in Namibia.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group
plc, a leading private healthcare group based in the United Kingdom
and listed on the LSE.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Caroline Emmet
+44 (0)20 7954 9569
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Ben Atwell/Ciara Martin - United Kingdom
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address : 6th Floor, 65 Gresham Street, London, EC2V
7NQ, United Kingdom
Website : www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International
plc and UBS Investment Bank
JSE sponsor : Rand Merchant Bank (A division of FirstRand Bank
Limited)
NSX sponsor : Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAPPUACPUPUGQU
(END) Dow Jones Newswires
February 21, 2020 05:00 ET (10:00 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024